Drug injection device for treating female vulvar leukoplakia

By designing a drug injection device suitable for female vulvar leukoplakia, using a cylindrical and ring-shaped cavity structure, combined with a drug patch and a flushing needle, simultaneous drug administration to the vulva and vagina is achieved, solving the problems of inconvenient operation and poor treatment effect in existing technologies, and improving treatment efficacy and convenience.

CN116099117BActive Publication Date: 2024-11-01SHENYANG SHENDA HOSPITAL CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310130323.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-02-17
Publication Date
2024-11-01
Estimated Expiration
2043-02-17

AI Technical Summary

Technical Problem

In existing technologies, medication application devices for treating vulvar leukoplakia in women cannot treat the vulva and vagina simultaneously, resulting in inconvenient operation, lack of personalized experience, and poor treatment effects.

Method used

A drug injection device was designed, comprising a syringe, piston, piston rod, drug delivery connector, drug application patch, and flushing needle. The device holds drugs in cylindrical and annular cavities respectively, and combines the drug application patch and flushing needle to achieve simultaneous drug delivery to the vulva and vagina. The device uses an elliptical or rhomboid patch that is adapted to the vulva, providing stability and accuracy.

Benefits of technology

It enables simultaneous treatment of the vulva and vagina, improving treatment effectiveness, shortening the treatment course, reducing the risk of cross-infection, and enhancing the ease of operation and personalized treatment experience.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116099117B_ABST
    Figure CN116099117B_ABST
Patent Text Reader

Abstract

The invention discloses a drug injection device for treating female vulvar leukoplakia, comprising a syringe, a first piston, a second piston, a first piston rod, a second piston rod, a drug adding joint, a drug applying patch and a flushing needle. The syringe has a cylindrical inner cavity and an annular cavity coaxially arranged around the cylindrical inner cavity. The cylindrical inner cavity and the annular cavity are respectively independent closed spaces separated by the inner cavity barrel wall. The cylindrical inner cavity and the annular cavity are used to hold different drugs, which meets the needs of symptomatic treatment. With the structures such as the drug applying patch and the flushing needle, synchronous drug application to different parts of the human body is achieved under the action of the first piston and the second piston. The elliptical or rhombus-shaped drug applying patch is compatible with the shape of the human vulva, can achieve close fitting and positioning, and is easy to operate, meeting the patient's needs for synchronous treatment of vulvar leukoplakia and its complications such as vaginitis. The operation is convenient, the treatment course of vulvar leukoplakia can be shortened, and the comprehensive treatment effect is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of medical devices, and in particular to a drug injection device for treating female vulvar leukoplakia, which is suitable for treating and improving female vulvar leukoplakia and complications such as vulvar lichen sclerosus, vaginal adhesions, vaginitis, etc., and can enable medication to be administered to the vagina while being administered to the vulva, thereby better helping doctors or patients to accurately locate medication application sites during treatment, and to reasonably administer medication to multiple sites at one time, thereby reducing the number of medication applications, avoiding cross infection, and improving treatment effects. Background Art

[0002] Vulvar skin and mucosal diseases are common in gynecological diagnosis and treatment. Chronic vulvar lesions in women include vulvar pruritus, vulvar eczema, vulvar leukoplakia, vulvar neurodermatitis, etc. Among them, vulvar leukoplakia, also known as vulvar white lesions, refers to localized or diffuse white patches that appear on the skin of the female genitals. In fact, it is a disease of tissue degeneration and pigment changes caused by local nerve and vascular nutrition disorders of the vulva, so it is sometimes called vulvar malnutrition. It is mostly caused by endocrine disorders, disorders, low immunity, abnormalities, local estrogen deficiency, etc. Clinical manifestations include hypopigmentation, whiteness, keratinization, roughness, thickening, desquamation, hardening, fissures, ulcers, atrophy of the labia majora and minora, itching or unbearable itching, etc., which seriously endanger people's physical and mental health and affect the normal work and life of patients. Generally, patients with mild symptoms can apply estrogen ointment to avoid the spread of the disease, or prevent itching, reduce inflammation, moisturize and improve nutrition, and pay attention to the cleanliness and hygiene of the local skin at ordinary times, change underwear regularly for cleaning, and avoid wearing tight underwear to reduce friction.

[0003] In addition, as the disease progresses, some patients may develop complications such as vaginitis, vaginal adhesions, vulvar cancer, etc. due to decreased immunity, dysbacteriosis and long-term stimulation of inflammation. If women themselves suffer from vaginitis, cervicitis or pelvic inflammatory disease, which are prone to cause increased vaginal discharge, they should actively undergo simultaneous treatment to avoid long-term stimulation of the vulvar skin by inflammatory secretions, which aggravates the development of vulvar leukoplakia. Therefore, while treating vulvar leukoplakia, it is necessary to consider the simultaneous treatment of vaginal inflammation or other related diseases in order to obtain a more ideal treatment effect and meet the convenience and personalized treatment needs of different patients.

[0004] In summary, in order to provide more comprehensive treatment for female vulvar leukoplakia, an improved injection device that is safe, reliable, easy to operate, and effective for treating the corresponding disease is needed. The device can flush the vagina or perform simultaneous treatment while treating vulvar leukoplakia, thereby playing a role in comprehensive treatment to make up for the shortcomings of the existing technology. Summary of the invention

[0005] The purpose of the present invention is to provide a drug injection device for treating female vulvar leukoplakia to solve the above-mentioned problems existing in the prior art. It has a shape structure adapted to the human vulva and surrounding parts, and a personalized structure that meets the needs of treatment, and can be adjusted accordingly according to the needs of use. It has suitable stability, accurate positioning, convenience of use, and safety and effectiveness of treatment, thereby improving the treatment effect of vulvar leukoplakia, greatly shortening the course of treatment, and reducing the psychological and economic burdens on patients.

[0006] To achieve the above-mentioned purpose, the present invention provides a drug injection device for treating female vulvar leukoplakia, comprising a syringe, a first piston, a second piston, a first piston rod, a second piston rod, a drug adding joint, a drug patch, a flushing needle and other structures. The syringe has a cylindrical inner cavity and an annular cavity coaxially arranged around the cylindrical inner cavity. The cylindrical inner cavity and the annular cavity are separated by the inner cavity wall to form independent closed spaces, which are respectively used to contain different drugs to act on different parts of the human body at the same time. The cylindrical inner cavity is provided with a first piston and a first piston rod fixedly connected to the center position of the first piston. The first piston has a cross-sectional shape consistent with the shape of the cylindrical inner cavity, such as a circle or a square. The annular cavity is provided with a second piston and a second piston rod fixedly connected to the second piston. The second piston has an annular structure consistent with the shape of the annular cavity, as well as an inner ring tightly attached to the inner cavity wall and an outer ring tightly attached to the syringe wall. The second piston rod is a hollow cylinder and has a hollow structure on the surrounding rod wall. The circular area where the second piston rod is connected to the second piston is located between the inner ring and the outer ring of the second piston, so that a relatively uniform thrust can be generated on the second piston when the second piston rod is pushed. An annular space is formed between the first piston rod and the second piston rod, and the top ends of the first piston rod and the second piston rod are connected to the same piston pushing part. When the piston pushing part is pressed, a thrust can be applied to the first piston rod and the second piston rod at the same time; a drug adding joint is provided on the outer wall of the end of the injection barrel away from the piston pushing part, which is used to be connected to a medicine bottle or a medicine bag, and the drug adding joint includes a tube body extending laterally from the outer wall of the injection barrel and an interface located at the free end of the tube body that can be sealed and connected to a medicine bottle or a medicine bag; a flushing needle and a medicine patch are connected to the distal end of the injection barrel away from the piston pushing part, the flushing needle is connected to the cylindrical inner cavity, and the medicine patch is connected to the annular cavity.

[0007] Furthermore, the flushing needle is cylindrical and extends radially along the syringe barrel, and a plurality of flushing holes are arranged at intervals on the outer wall of the flushing needle body. There are 3-4 flushing ports symmetrically arranged near the tip of the flushing needle and a flushing nozzle located at the tip surrounded by the flushing ports. When in use, the flushing needle is inserted into the human vagina, and the first piston rod is pushed. The medicine in the cylindrical inner cavity can flow out through the flushing holes, the flushing ports and the flushing nozzle to flush and treat the vagina. The flushing needle is fixedly connected or detachably connected to the syringe barrel.

[0008] Furthermore, the medicine patch extends laterally along the injection barrel around the connection between the flushing needle and the injection barrel, and has an elliptical or diamond-like structure, which is adapted to the shape of the human vulva. The medicine patch has several extrusion ports that allow the drug in the annular cavity to flow out. When in use, the medicine patch is attached to the human vulva, and the second piston rod is pushed. The drug in the annular cavity can flow out through the extrusion ports to apply medicine and treat the area around the vulva. The medicine patch is fixedly connected to the injection barrel as an integrated structure.

[0009] Preferably, the medicine patch has a microneedle structure and / or a massage magnetic head.

[0010] Preferably, the first piston and the second piston have the same thickness and material. When the first piston rod and the second piston rod are pushed to apply medicine, the first piston and the second piston are always kept on the same horizontal plane. When external force is applied to the piston pushing part, the first piston and the second piston can move synchronously.

[0011] Preferably, a one-way valve allowing the drug to flow into the annular cavity of the syringe is provided on the tube body of the drug adding connector, and the interface at the free end of the tube body is a threaded port, a clamp or a snap-on quick interface, which facilitates the rapid installation and replacement of medicine bottles or medicine bags.

[0012] Furthermore, a support bracket extending laterally along the syringe is provided at a proximal portion of the syringe near the piston pushing portion. When in use, the support bracket can be clamped by fingers to facilitate forcing the piston pushing portion.

[0013] Furthermore, an elastic drug storage bag is symmetrically arranged at the short axis of the medicine patch to buffer and store the medicine squeezed out of the annular cavity, and the drug storage bag is made of an elastic polymer material.

[0014] Preferably, the distal end of the injection barrel close to the medicine patch is stepped, that is, the outer diameter of the distal end of the injection barrel increases from near to far in a step-like manner, and the closer to the medicine patch, the larger the outer diameter of the injection barrel.

[0015] Furthermore, when the medicine is used up, the medicine in the cylindrical inner cavity can be inhaled and replenished through the flushing needle, and the medicine in the annular cavity can be inhaled and replenished through the dosing connector, and the volume of the cylindrical inner cavity is greater than or equal to the volume of the annular cavity.

[0016] The medicine in the cylindrical inner cavity is a liquid or ointment for treating vaginal complications such as vaginitis and vaginal adhesions, including but not limited to Fuyanjie wash, Jie'eryin wash, Bai'an wash, Honghe wash, Keyangshu wash, compound Huangbo liquid, potassium permanganate wash, baking soda solution, clindamycin, ciprofloxacin, Jiaoyan gel disinfectant, and compound Huangteng wash and other traditional Chinese medicine washes; the medicine in the annular cavity is an ointment or liquid for treating vulvar leukoplakia, including but not limited to fluocinolone ointment, triamcinolone acetonide ointment, pyruvic acid ointment, complex vitamin A ointment, hydrocortisone ointment, testosterone propionate cod liver oil ointment, progesterone ointment, erythromycin ointment, cod liver oil ointment, vitamin B12 injection, procaine injection, dexamethasone injection, Baizhi Qushi wash, Huangku wash, Artemisia capillaris wash or other traditional Chinese medicine preparations.

[0017] Compared with the prior art, the present invention has the following beneficial technical effects:

[0018] The present invention adopts the above technical scheme to solve the shortcomings of the drug application device for treating female vulvar leukoplakia in the prior art, such as the inability to perform synchronous treatment, poor treatment effect, inconvenient operation, lack of personalized treatment experience, etc., and meets the patient's synchronous treatment of vulvar leukoplakia and its complications such as vaginitis. The operation is convenient, and the course of treatment of vulvar leukoplakia can be shortened, and the comprehensive treatment effect can be improved. Among them, the cylindrical inner cavity and the annular cavity used to hold different drugs meet the needs of symptomatic treatment. With the structures such as the drug application patch and the flushing needle, the synchronous drug application to different parts of the human body is achieved under the action of the first piston and the second piston. The elliptical or rhombus-shaped drug application patch is compatible with the shape of the human vulva, and can achieve close fitting and positioning, which is convenient to operate. The various structures of the present invention are reasonably coordinated to form an organic whole, and the synergistic effect solves the above-mentioned shortcomings in the prior art and achieves a good treatment effect of vulvar leukoplakia. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 It is a schematic diagram of the overall structure of the drug injection device of the present invention;

[0020] Figure 2 It is a schematic diagram of the overall structure of the flushing needle of the present invention;

[0021] Figure 3 It is a schematic structural diagram of the medicine-applying patch of the present invention;

[0022] Figure 4 This is a schematic diagram of the distal stepped injection barrel structure of the present invention;

[0023] Figure 5 It is a main cross-sectional view of the medicine patch of the present invention. DETAILED DESCRIPTION

[0024] The following will be combined with the drawings in the embodiments of the present invention to clearly and completely describe the technical solutions in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other related embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0025] Example 1

[0026] See attached Figure 1-2 As shown, the present invention provides a drug injection device for treating female vulvar leukoplakia, comprising a syringe 1, a first piston 2, a second piston 3, a first piston rod 4, a second piston rod 5, a drug adding joint 6, a drug patch 7, a flushing needle 8 and other structures. The syringe 1 has a cylindrical inner cavity and an annular cavity coaxially arranged around the cylindrical inner cavity. The cylindrical inner cavity and the annular cavity are respectively independent closed spaces separated by an inner cavity wall 9, and are respectively used to contain different drugs to act on different parts of the human body at the same time. The cylindrical inner cavity is provided with a first piston 2 and a first piston rod 4 fixedly connected to the center position of the first piston 2. The first piston 2 has a cross-sectional shape consistent with the shape of the cylindrical inner cavity, such as a circle or a square. The annular cavity is provided with a second piston 3 and a second piston rod 5 fixedly connected to the second piston 3. The second piston 3 has an annular structure consistent with the shape of the annular cavity, as well as an inner ring tightly attached to the inner cavity wall 9 and an outer ring tightly attached to the inner wall of the syringe 1. The second piston rod 5 is centrally The second piston rod 5 is hollow cylindrical and has a hollow structure on the surrounding rod wall. The circular area where the second piston rod 5 is connected to the second piston 3 is located between the inner circle and the outer circle of the second piston 3, so that when the second piston rod 5 is pushed and extruded, a relatively uniform thrust can be generated on the second piston 3. An annular space is formed between the first piston rod 4 and the second piston rod 5, and the top ends of the first piston rod 4 and the second piston rod 5 are connected to the same piston pushing part 10. When the piston pushing part 10 is pressed, the first piston rod 4 and the second piston rod 5 can be pushed. The stopper rod 5 applies a thrust at the same time; a dosing connector 6 is provided on the outer wall of one end of the injection barrel 1 away from the piston pushing portion 10, which is used to be connected to a medicine bottle or a medicine bag 11, and the dosing connector 6 includes a tube body extending laterally from the outer wall of the injection barrel and an interface located at the free end of the tube body that can be sealed and connected to a medicine bottle or a medicine bag; a flushing needle 8 and a medicine patch 7 are connected to the distal end of the injection barrel 1 away from the piston pushing portion 10, the flushing needle 8 is connected to the cylindrical inner cavity, and the medicine patch 7 is connected to the annular cavity.

[0027] Furthermore, the flushing needle 8 is cylindrical and extends radially along the syringe barrel. A plurality of flushing holes 12 are arranged at intervals on the outer wall of the flushing needle 8 body. The flushing needle 8 has 3-4 flushing ports 13 arranged symmetrically near the tip and a flushing nozzle 14 located at the tip and surrounded by the flushing ports. When in use, the flushing needle 8 is inserted into the human vagina, and the first piston rod 4 is pushed. The medicine in the cylindrical inner cavity can flow out through the flushing holes 12, the flushing ports 13 and the flushing nozzle 14 to flush and treat the vagina. The flushing needle 8 is fixedly connected or detachably connected to the syringe barrel 1, preferably detachably connected, so as to facilitate timely cleaning and replacement.

[0028] Further, the medicine patch 7 extends transversely along the injection barrel 1 around the connection between the flushing needle 8 and the injection barrel 1, and has an elliptical or rhombus-like structure, which is adapted to the shape of the human vulva. At the same time, the body of the medicine patch 7 has a concave structure, that is, the body of the medicine patch 7 is arc-shaped and concave from the edge to the center, so as to be more convenient to attach to the human vulva; preferably, a protruding rubber flange is provided at the edge of the medicine patch 7, so as to be more convenient to fit with the skin of the vulva. The medicine patch 7 has a plurality of extrusion ports that allow the drug in the annular cavity to flow out. In this embodiment, the extrusion ports are through holes provided on the medicine patch; when in use, the medicine patch 7 is attached to the human vulva, and the second piston rod 5 is pushed, and the drug in the annular cavity can flow out through the extrusion ports to apply and treat the surrounding of the vulva. The medicine patch 7 is fixedly connected to the injection barrel 1 as an integrated structure.

[0029] Preferably, the first piston 2 and the second piston 3 have the same thickness and material. When pushing the first piston rod 4 and the second piston rod 5 to apply the medicine, the first piston 2 and the second piston 3 always remain on the same horizontal plane. When external force is applied to the piston pushing part 10, the first piston 2 and the second piston 3 can move synchronously.

[0030] Preferably, a one-way valve 15 is provided on the tube body of the drug adding connector 6 to allow the drug to flow into the annular cavity of the syringe, and the interface at the free end of the tube body is a threaded port, a clamp or a snap-on quick interface, which facilitates the rapid installation and replacement of the medicine bottle or bag 11.

[0031] Furthermore, when the medicine is used up, the medicine in the cylindrical inner cavity can be inhaled and replenished through the flushing needle 8, and the medicine in the annular cavity can be inhaled and replenished through the dosing connector 6, and the volume of the cylindrical inner cavity is greater than or equal to the volume of the annular cavity.

[0032] Furthermore, a support bracket 16 extending laterally along the syringe is provided at a proximal portion of the syringe 1 close to the piston pushing portion 10 . When in use, the support bracket 16 can be clamped by fingers to facilitate pushing the piston pushing portion 10 with force.

[0033] See attached Figure 3 As shown, an elastic drug storage bag 17 is symmetrically provided at the short axis of the medicine patch 7 to buffer and store the medicine squeezed out from the annular cavity, and the drug storage bag 17 is made of an elastic polymer material.

[0034] In this embodiment, the medicine in the cylindrical inner cavity is a liquid or ointment for treating vaginal complications such as vaginitis and vaginal adhesions, including but not limited to Fuyanjie wash, Jie'eryin wash, Bai'an wash, Honghe wash, Keyangshu wash, compound Huangbo liquid, potassium permanganate wash, baking soda solution, clindamycin, ciprofloxacin, Jiaoyan gel disinfectant, and compound Huangteng wash and other traditional Chinese medicine washes; the medicine in the annular cavity is an ointment or liquid for treating vulvar leukoplakia, including but not limited to fluocinolone ointment, triamcinolone acetonide ointment, pyruvic acid ointment, complex vitamin A ointment, hydrocortisone ointment, testosterone propionate cod liver oil ointment, progesterone ointment, erythromycin ointment, cod liver oil ointment, vitamin B12 injection, procaine injection, dexamethasone injection, Baizhi Qushi wash, Huangku wash, Artemisia capillaris wash or other traditional Chinese medicine preparations. After applying the medicine, you can use cotton wool or gauze to absorb excess medicine, and put on sanitary napkins or panty liners in time to keep the vulva dry and clean.

[0035] Example 2

[0036] like Figure 4 As shown, the structure of this embodiment is basically the same as that of embodiment 1, except that, in this embodiment, the distal end of the injection barrel 1 close to the medicine patch 7 is stepped, that is, the outer diameter of the distal end of the injection barrel 1 increases from near to far in a step-like manner, and the closer to the medicine patch 7, the larger the outer diameter of the injection barrel 1.

[0037] In this embodiment, the inner wall of the syringe 1 is a smooth and flat structure without a step-like structure, that is, the step-like structure is only provided on the outer wall of the syringe 1, thereby achieving stable fitting of the medicine patch 7 with the human body. In addition, as a preferred embodiment, a photosensitive disinfection element may be provided on the flushing needle 8 and / or the medicine patch 7 to facilitate sterilization and disinfection by light, and a searchlight and a camera may be provided at the tip of the flushing needle 8, and an observation window connected to the searchlight and the camera may be provided on the syringe 1 to facilitate real-time observation of the environment and state inside the vagina.

[0038] Example 3

[0039] Continue to refer to the attached Figure 1-4As shown, the structure of this embodiment is basically the same as that of embodiment 2, except that, in this embodiment, a microneedle structure 18 is provided on the medicine patch to replace the extrusion port on the medicine patch, and the microneedle structure 18 has a hollow microneedle body integrally formed with the medicine patch 7, and the microneedle structure 18 is connected to the annular cavity. When the piston pushing portion 10 is pushed to move the second piston 3, the drug in the annular cavity can be injected into the epidermis of the human vulva through the microneedle structure 18, or directly act on the surface of the vulva through the microneedle structure 18 and allow the drug to penetrate into the skin under the stimulation of the microneedle, so as to achieve a better therapeutic effect. Preferably, the surface of the medicine patch 7 body that fits the human skin has an oval or half-moon arc-shaped concave structure symmetrically arranged along the long axis direction of the medicine patch 7, so as to adapt to the shape of the human vulva, and is more conducive to the microneedle stimulating the same degree of different positions of the human skin.

[0040] Example 4

[0041] like Figure 5 As shown, the structure of this embodiment is basically the same as that of Embodiment 3, except that, in this embodiment, as another alternative, microneedle structures 18 and magnetic therapy bumps (or massage magnetic heads) 19 are provided on the medicine patch at intervals, and a magnetic therapy bump 19 is provided between each two adjacent microneedle structures 18.

[0042] In this embodiment, the microneedle structure 18 has a hollow microneedle body integrally formed with the medicine patch 7, the microneedle structure 18 is connected to the annular cavity, and the microneedle body of the microneedle structure 18 is composed of a microneedle base layer 20 that penetrates the interior of the medicine patch, that is, the microneedle base layer 20 as a whole constitutes a plurality of microneedle structures 18 in this embodiment, and adjacent microneedle structures 18 are interconnected by the microneedle base layer 20 to form an integrated structure, and the magnetic therapy bump 19 is embedded in the body of the medicine patch 7 between adjacent microneedle structures 18, and the height of the magnetic therapy bump 19 protruding from the body of the medicine patch 7 is the same as that of the microneedle structure 18, that is, the tip of the magnetic therapy bump 19 and the microneedle structure 18 are basically in the same horizontal plane, and the magnetic therapy bump 19 is a solid structure made of magnetic material. The micromagnetic field generated by the magnetic therapy protrusion 19 can affect the current distribution, movement of charged particles, permeability of the membrane system, and magnetic moment orientation of biopolymers in the human vulva, thereby changing the physiological and biochemical processes of tissue cells, producing analgesic and detumescent effects, accelerating the excretion of intracellular waste and harmful substances, promoting blood circulation and cell metabolism, and improving microcirculation. The therapeutic effect of vulvar leukoplakia can be further improved by combining drugs and magnetic therapy massage.

[0043] Furthermore, as is known to those skilled in the art, this embodiment may also additionally include other control mechanisms, drive mechanisms, power sources and / or auxiliary structures to perform necessary control and operation, without departing from the spirit of the invention and without causing structural interference between the structures, and can be implemented by those skilled in the art.

[0044] It is obvious to those skilled in the art that the present invention is not limited to the details of the exemplary embodiments described above, and that the present invention can be implemented in other specific forms or combinations thereof without departing from the spirit or essential features of the present invention. Therefore, the scope of the present invention is defined by the appended claims rather than the above description, and it is intended that all changes falling within the meaning and scope of the equivalent elements of the claims be included in the present invention.

[0045] In addition, it should be understood that although the present specification is described according to implementation modes, not every implementation mode contains only one independent technical solution. This description of the specification is only for the sake of clarity. Those skilled in the art should regard the specification as a whole. The technical solutions in each embodiment may also be appropriately combined to form other implementation modes that can be understood by those skilled in the art.

Claims

1. A drug injection device for treating female vulvar leukoplakia, comprising a syringe, a first piston, a second piston, a first piston rod, a second piston rod, a drug adding joint, a drug patch and a flushing needle, wherein the syringe has a cylindrical inner cavity and an annular cavity coaxially arranged around the cylindrical inner cavity, wherein the cylindrical inner cavity and the annular cavity are respectively independent closed spaces separated by the inner cavity wall, wherein the cylindrical inner cavity is provided with a first piston and a first piston rod fixedly connected to the center position of the first piston, wherein the first piston has a cross-sectional shape consistent with the shape of the cylindrical inner cavity, wherein the annular cavity is provided with a second piston and a second piston rod fixedly connected to the second piston, wherein the second piston has an annular structure consistent with the shape of the annular cavity, and an inner ring closely attached to the inner cavity wall and an outer ring closely attached to the inner wall of the syringe, wherein the second piston rod is hollow The syringe is cylindrical and has a hollow structure on the surrounding rod wall. The circular area where the second piston rod is connected to the second piston is located between the inner ring and the outer ring of the second piston. An annular space is formed between the first piston rod and the second piston rod, and the top ends of the first piston rod and the second piston rod are connected to the same piston pushing part. When the piston pushing part is pressed, a thrust can be applied to the first piston rod and the second piston rod at the same time; a dosing connector for connecting to a medicine bottle or a medicine bag is provided on the outer wall of the end of the syringe away from the piston pushing part, and the dosing connector includes a tube body extending laterally from the outer wall of the syringe and an interface located at the free end of the tube body that can be sealed and connected to a medicine bottle or a medicine bag; a flushing needle and a medicine patch are connected to the distal end of the syringe away from the piston pushing part, the flushing needle is connected to the cylindrical inner cavity, and the medicine patch is connected to the annular cavity; The flushing needle is cylindrical and extends radially along the syringe barrel. A plurality of flushing holes are arranged at intervals on the outer wall of the flushing needle body. There are 3-4 flushing ports symmetrically arranged near the tip of the flushing needle and a flushing nozzle surrounded by the flushing ports and located at the tip. The flushing needle is used to be inserted into the human vagina and is detachably connected to the syringe barrel. The medicine patch extends transversely along the injection barrel around the connection between the flushing needle and the injection barrel, and has an elliptical or rhombus-like structure, adapted to the shape of the human vulva, and the medicine patch has a concave structure to facilitate attachment to the human vulva; a microneedle structure is provided on the medicine patch, the microneedle structure is connected to the annular cavity and has a hollow microneedle body integrally formed with the medicine patch; The medicine in the cylindrical inner cavity can be inhaled and supplemented through the flushing needle, and the medicine in the annular cavity can be inhaled and supplemented through the medicine adding connector. The volume of the cylindrical inner cavity is greater than or equal to the volume of the annular cavity.

2. According to the drug injection device according to claim 1, microneedle structures and magnetic therapy bumps are arranged on the medicine patch at intervals, and a magnetic therapy bump is arranged between each two adjacent microneedle structures. The magnetic therapy bump is embedded in the medicine patch body between adjacent microneedle structures, and the height of the magnetic therapy bump protruding from the medicine patch body is the same as that of the microneedle structure, and the magnetic therapy bump is a solid structure made of magnetic material.

3. According to the drug injection device of claim 1, the first piston and the second piston have the same thickness and material. When the first piston rod and the second piston rod are pushed to administer the medicine, the first piston and the second piston are always maintained on the same horizontal plane. When external force is applied to the piston pushing part, the first piston and the second piston can move synchronously.

4. The drug injection device according to any one of claims 1 to 3, wherein the tube body of the drug adding connector is provided with a one-way valve allowing the drug to flow into the annular cavity of the syringe, and the interface at the free end of the tube body is a threaded port, a clamp or a buckle-type quick interface.

5. The drug injection device according to any one of claims 1 to 3, wherein a support bracket extending laterally along the syringe is provided at a proximal portion of the syringe barrel near the piston pushing portion, and the piston pushing portion can be pushed forcefully by clamping the support bracket with fingers.

6. The drug injection device according to claim 1, wherein an elastic drug storage bag is symmetrically provided at the short axis of the drug patch, and the drug storage bag is made of an elastic polymer material and can buffer and store the drug squeezed out of the annular cavity.

7. The drug injection device according to any one of claims 1 to 3 or claim 6, wherein the drug in the cylindrical inner cavity is a liquid or ointment for treating intravaginal complications, and the drug in the annular cavity is an ointment or liquid for treating vulvar leukoplakia.